Abstract:Cytotoxic T lymphocytes and NK cells play an important role in eliminating malignant tumor cells and the number and activity of tumor-infiltrating T cells represent a good marker for tumor prognosis. Based on these findings, immunotherapy, e.g., checkpoint blockade, has received considerable attention during the last couple of years. However, for the majority of patients, immune control of their tumors is gray theory as malignant cells use effective mechanisms to outsmart the immune system. Increasing evidence suggests that changes in tumor metabolism not only ensure an effective energy supply and generation of building blocks for tumor growth but also contribute to inhibition of the antitumor response. Immunosuppression in the tumor microenvironment is often based on the mutual metabolic requirements of immune cells and tumor cells. Cytotoxic T and NK cell activation leads to an increased demand for glucose and amino acids, a well-known feature shown by tumor cells. These close metabolic interdependencies result in metabolic competition, limiting the proliferation, and effector functions of tumor-specific immune cells. Moreover, not only nutrient restriction but also tumor-driven shifts in metabolite abundance and accumulation of metabolic waste products (e.g., lactate) lead to local immunosuppression, thereby facilitating tumor progression and metastasis. In this review, we describe the metabolic interplay between immune cells and tumor cells and discuss tumor cell metabolism as a target structure for cancer therapy. Metabolic (re)education of tumor cells is not only an approach to kill tumor cells directly but could overcome metabolic immunosuppression in the tumor microenvironment and thereby facilitate immunotherapy.

Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer

Targeting metabolism to enhance immunotherapy within tumor microenvironment

Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy

Targeting T Cell Metabolism in the Tumor Microenvironment: an Anti-Cancer Therapeutic Strategy

Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment

Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy

Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy

Metabolic interventions: A new insight into the cancer immunotherapy

Metabolic communication in the tumour–immune microenvironment

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment

Immunological Aspects of Cancer Cell Metabolism

Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy

Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance

Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer

Targeting cellular metabolism to improve cancer therapeutics

Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment

T cell dysfunction and therapeutic intervention in cancer

Metabolic hallmarks of natural killer cells in the tumor microenvironment and implications in cancer immunotherapy

Immunometabolism and natural killer cell responses